|Last Price$32.68||Day Change (%)-0.35%|
|Open Price$32.34||Day Change ($)-0.12|
|Day Range32.30–33.35||52-Week Range27.51–33.50|
As of Tue 01/27/2015 03:32 PM EST | USD
Research and Markets: OTC Pharmaceuticals: Global Industry Guide 2014-2018: Market to value $170,812.0m by the end of 2018
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...
Inside Clipper Fund's makeover.
Recent deals have been driven more by tax strategies than therapeutic synergies.
We believe breakups could unlock value for big pharma shareholders.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
Things look grim, but investors who can bear it could benefit.
Inspired by a vessel that brought Swedes to the New World, Draper has built a firm that emphasizes results over renown.
ETFs provide a great means to gain exposure to this battered health-care giant.